A 48-year-old man with HIV has coinfection with hepatitis C virus (HCV). Laboratory studies show a CD4 count of 623 cells/mm3, an undetectable HIV RNA level, and an HCV RNA level of 7 million IU/mL. Noninvasive evaluation of liver fibrosis indicates that he does not have cirrhosis. He has never received therapy for HCV and is scheduled to start treatment for HCV at the next visit.
In this man with HIV, when treating HCV using a recommended pangenotypic oral regimen, what is the expected likelihood of achieving a sustained virologic response at 12 weeks (SVR12)?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
February 1st, 2025
February 1st, 2025
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5